Red X iconGreen tick iconYellow tick icon

Contact Details

Phone
64 3 556 6258
Email
euan.rodger@otago.ac.nz
Position
Senior Research Fellow
Department
Department of Pathology and Molecular Medicine (Dunedin)
Qualifications
MSc PhD
Research summary
Cancer epigenetics
Teaching
  • PATH 301 Applied Pathology
  • PATH 302 Cancer Biology
  • GENE412 Current Topics in Genetics
  • BINF701 Introduction to Clinical Bioinformatics
Memberships
  • European Association of Cancer Research
  • Australasian Liquid Biopsy Society
  • International Epigenome Consortium (IHEC)
  • Australian Epigenetics Alliance (AEpiA)
  • Maurice Wilkins Centre for Biodiscovery
  • New Zealand Society for Oncology
  • Genetics Otago
  • Epigenetics User Group (EUG), Otago

Research

Dr Rodger is dedicated to leading world-class cancer epigenetics research identifying novel candidate biomarkers, advancing the knowledge of epigenetic changes underpinning various disease states, and contributing to outcomes with clinically relevant impact. Currently, his research is focused on uncovering epigenetic mechanisms driving metastasis across multiple cancer types, mapping the epigenome of circulating tumour DNA to develop blood-based diagnostics, and targeting epigenetic factors underlying cancer therapy resistance.

Publications

Sharma, S., Hodges, L. D., Peppercorn, K., Davis, J., Edgar, C. D., Rodger, E. J., Chatterjee, A., & Tate, W. P. (2025). Precision medicine study of post-exertional malaise epigenetic changes in myalgic encephalomyelitis/chronic fatigue patients during exercise. International Journal of Molecular Sciences, 26, 8563. doi: 10.3390/ijms26178563 Journal - Research Article

Peppercorn, K., Sharma, S., Edgar, C. D., Stockwell, P. A., Rodger, E. J., Chatterjee, A., & Tate, W. P. (2025). Comparing DNA methylation landscapes in peripheral blood from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID patients. International Journal of Molecular Sciences, 26, 6631. doi: 10.3390/ijms26146631 Journal - Research Article

Sharma, S., Peppercorn, K., Rodger, E., Tate, W., & Chatterjee, A. (2025, February). Developing a blood-based epigenomic signature for ME/CFS and Long COVID using Peripheral Blood Mononuclear Cells (PBMCs). Poster session presented at the Maurice Wilkins Centre (MWC) Research Symposium, Auckland, New Zealand. Conference Contribution - Poster Presentation (not in published proceedings)

Peppercorn, K., Edgar, C. D., Al Momani, S., Rodger, E. J., Tate, W. P., & Chatterjee, A. (2025). Application of DNA methylome analysis to patients with ME/CFS. In W. P. Tate & K. Peppercorn (Eds.), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Methods and protocols: Methods in molecular biology (Vol. 2920). (pp. 141-160). New York, NY: Humana Press. doi: 10.1007/978-1-0716-4498-0_9 Chapter in Book - Research

Hossain, S. M., Gimenez, G., Stockwell, P., Weeks, R., Almomani, S., Jones, G. T., Ratajska, M., Shuen, M., Bhat, B., … Rodger, E., Jackson, C., Chatterjee, A., & Eccles, M. R. (2025). Pre-treatment DNA methylome and transcriptome profiles correlate with melanoma response to anti-PD1 immunotherapy. Cancer Letters, 618, 217638. doi: 10.1016/j.canlet.2025.217638 Journal - Research Article

Back to top